메뉴 건너뛰기




Volumn 36, Issue 10, 1998, Pages 2950-2956

Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts

Author keywords

[No Author keywords available]

Indexed keywords

ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; ECHINOCANDIN B; POSACONAZOLE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

EID: 0031689491     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.10.2950-2956.1998     Document Type: Article
Times cited : (543)

References (33)
  • 1
    • 85047696806 scopus 로고
    • Opportunistic mycoses in the immunocompromised host: Experience at a cancer center and review
    • Anaissic, E. 1992. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin. Infect. Dis. 14:S43-S53.
    • (1992) Clin. Infect. Dis. , vol.14
    • Anaissic, E.1
  • 3
    • 0030854825 scopus 로고    scopus 로고
    • In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds
    • Del Poeta, M., W. A. Schell, and J. R. Perfect. 1997. In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds. Antimicrob. Agents Chemother. 41:1835-1836.
    • (1997) Antimicrob. Agents Chemother. , vol.41 , pp. 1835-1836
    • Del Poeta, M.1    Schell, W.A.2    Perfect, J.R.3
  • 5
    • 0031974507 scopus 로고    scopus 로고
    • In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens
    • Espinel-Ingroff, A. 1998. In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens. J. Clin. Microbiol. 36:198-202.
    • (1998) J. Clin. Microbiol. , vol.36 , pp. 198-202
    • Espinel-Ingroff, A.1
  • 8
    • 0026737730 scopus 로고
    • Candidemia in a tertiary care hospital: Epidemiology, risk factors, and predictors of mortality
    • Fraser, V. J., M. Jones, J. Dunkel, S. Storfer, G. Medoff, and W. C. Dunagan. 1992. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin. Infect. Dis. 15:414-421.
    • (1992) Clin. Infect. Dis. , vol.15 , pp. 414-421
    • Fraser, V.J.1    Jones, M.2    Dunkel, J.3    Storfer, S.4    Medoff, G.5    Dunagan, W.C.6
  • 9
    • 0031027261 scopus 로고    scopus 로고
    • In vitro studies of activities of the antifungal triazoles SCH56592 and itraconazole against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts
    • Galgiani, J. N., and M. L. Lewis. 1997. In vitro studies of activities of the antifungal triazoles SCH56592 and itraconazole against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts. Antimicrob. Agents Chemother. 41:180-183.
    • (1997) Antimicrob. Agents Chemother. , vol.41 , pp. 180-183
    • Galgiani, J.N.1    Lewis, M.L.2
  • 12
    • 0029591535 scopus 로고
    • Fungal infections in solid organ transplant recipients
    • Hadley, S., and A. W. Karchmer. 1995. Fungal infections in solid organ transplant recipients. Infect. Dis. Clin. N. Am. 9:1045-1074.
    • (1995) Infect. Dis. Clin. N. Am. , vol.9 , pp. 1045-1074
    • Hadley, S.1    Karchmer, A.W.2
  • 13
    • 0029075535 scopus 로고
    • Epidemiology of nosocomial fungal infections, with emphasis on Candida species
    • Jarvis, W. R. 1995. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin. Infect. Dis. 20:1526-1530.
    • (1995) Clin. Infect. Dis. , vol.20 , pp. 1526-1530
    • Jarvis, W.R.1
  • 14
    • 3543113491 scopus 로고    scopus 로고
    • Antifungal agents in the 1990s: Current status and future developments
    • Kauffman, C. A., and P. L. Carver. 1997. Antifungal agents in the 1990s: current status and future developments. Drugs 63:639-649.
    • (1997) Drugs , vol.63 , pp. 639-649
    • Kauffman, C.A.1    Carver, P.L.2
  • 15
    • 0028146881 scopus 로고
    • Invasive aspergillosis in patients with AIDS
    • Khoo, S. H., and D. W. Denning. 1994. Invasive aspergillosis in patients with AIDS. Clin. Infect. Dis. 19:S41-S48.
    • (1994) Clin. Infect. Dis. , vol.19
    • Khoo, S.H.1    Denning, D.W.2
  • 16
    • 0030779919 scopus 로고    scopus 로고
    • Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans
    • Krishnarao, T., and J. N. Galgiani. 1997. Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans. Antimicrob. Agents Chemother. 41:1957-1960.
    • (1997) Antimicrob. Agents Chemother. , vol.41 , pp. 1957-1960
    • Krishnarao, T.1    Galgiani, J.N.2
  • 17
    • 0028283764 scopus 로고
    • Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-β-D-glucan synthase
    • Kurtz, M. B., I. B. Heath, J. Marrinan, S. Dreikorn, J. Onishi, and C. Douglas. 1994. Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-β-D-glucan synthase. Antimicrob. Agents Chemother. 38:1480-1489.
    • (1994) Antimicrob. Agents Chemother. , vol.38 , pp. 1480-1489
    • Kurtz, M.B.1    Heath, I.B.2    Marrinan, J.3    Dreikorn, S.4    Onishi, J.5    Douglas, C.6
  • 18
    • 0030821205 scopus 로고    scopus 로고
    • Activity of SCH56592 compared with those of fluconazole and itraconazole against Candida spp
    • Law, D., C. B. Moore, and D. W. Denning. 1997. Activity of SCH56592 compared with those of fluconazole and itraconazole against Candida spp. Antimicrob. Agents Chemother. 41:2310-2311.
    • (1997) Antimicrob. Agents Chemother. , vol.41 , pp. 2310-2311
    • Law, D.1    Moore, C.B.2    Denning, D.W.3
  • 20
    • 0016097131 scopus 로고
    • Storage of stock cultures of filamentous fungi, yeasts, and some aerobic actinomycetes in sterile, distilled water
    • McGinnis, M. R. 1974. Storage of stock cultures of filamentous fungi, yeasts, and some aerobic actinomycetes in sterile, distilled water. Appl. Microbiol. 28:218-222.
    • (1974) Appl. Microbiol. , vol.28 , pp. 218-222
    • McGinnis, M.R.1
  • 21
    • 0027532280 scopus 로고
    • The spectrum on non-Candida fungal infections following bone marrow transplantation
    • Baltimore
    • Morrison, V. A., R. J. Haake, and D. J. Weisdorf. 1993. The spectrum on non-Candida fungal infections following bone marrow transplantation. Medicine (Baltimore) 72:78-89.
    • (1993) Medicine , vol.72 , pp. 78-89
    • Morrison, V.A.1    Haake, R.J.2    Weisdorf, D.J.3
  • 24
    • 0030989041 scopus 로고    scopus 로고
    • In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp
    • Oakley, K. L., C. B. Moore, and D. W. Denning. 1997. In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp. Antimicrob. Agents Chemother. 41:1124-1126.
    • (1997) Antimicrob. Agents Chemother. , vol.41 , pp. 1124-1126
    • Oakley, K.L.1    Moore, C.B.2    Denning, D.W.3
  • 25
    • 0030845020 scopus 로고    scopus 로고
    • Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus
    • Oakley, K. L., G. Morrissey, and D. W. Denning. 1997. Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus. Antimicrob. Agents Chemother. 41:1504-1507.
    • (1997) Antimicrob. Agents Chemother. , vol.41 , pp. 1504-1507
    • Oakley, K.L.1    Morrissey, G.2    Denning, D.W.3
  • 26
    • 0024994257 scopus 로고
    • The epidemiology of pseudallescheriasis complicating transplantation: Nosocomial and community-acquired infection
    • Patterson, T. F., V. T. Andriole, M. J. Zervos, D. Therasse, and C. A. Kauffman. 1990. The epidemiology of pseudallescheriasis complicating transplantation: nosocomial and community-acquired infection. Mycoses 33:297-302.
    • (1990) Mycoses , vol.33 , pp. 297-302
    • Patterson, T.F.1    Andriole, V.T.2    Zervos, M.J.3    Therasse, D.4    Kauffman, C.A.5
  • 27
    • 0029817614 scopus 로고    scopus 로고
    • In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans
    • Perfect, J. R. G. M. Cox, R. K. Dodge, and W. A. Schell. 1996. In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans. Antimicrob. Agents Chemother. 40:1910-1913.
    • (1996) Antimicrob. Agents Chemother. , vol.40 , pp. 1910-1913
    • Perfect, J.R.1    Cox, G.M.2    Dodge, R.K.3    Schell, W.A.4
  • 28
    • 0030896916 scopus 로고    scopus 로고
    • In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agents
    • Pfaller, M. A., S. A. Messer, and S. Coffman. 1997. In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agents. Antimicrob. Agents Chemother. 41:763-766.
    • (1997) Antimicrob. Agents Chemother. , vol.41 , pp. 763-766
    • Pfaller, M.A.1    Messer, S.A.2    Coffman, S.3
  • 29
    • 0031982890 scopus 로고    scopus 로고
    • Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis
    • Rex, J. H., P. W. Nelson, V. L. Paetznick, M. Lozano-Chiu, A. Espinel-Ingroff, and E. J. Anaissie. 1998. Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis. Antimicrob. Agents Chemother. 42:129-134.
    • (1998) Antimicrob. Agents Chemother. , vol.42 , pp. 129-134
    • Rex, J.H.1    Nelson, P.W.2    Paetznick, V.L.3    Lozano-Chiu, M.4    Espinel-Ingroff, A.5    Anaissie, E.J.6
  • 30
    • 0030970811 scopus 로고    scopus 로고
    • In vitro activity of a new echinocandin. LY303366, compared with those of amphotericin B and fluconazole against clinical yeast isolates
    • Uzun, O., S. Kocagöz, Y. Çetinkaya, S. Arikan, and S. Ünal. 1997. In vitro activity of a new echinocandin. LY303366, compared with those of amphotericin B and fluconazole against clinical yeast isolates. Antimicrob. Agents Chemother. 41:1156-1157.
    • (1997) Antimicrob. Agents Chemother. , vol.41 , pp. 1156-1157
    • Uzun, O.1    Kocagöz, S.2    Çetinkaya, Y.3    Arikan, S.4    Ünal, S.5
  • 31
    • 0030757452 scopus 로고    scopus 로고
    • In vitro activity of a new pneumocandin antifungal, L-743,872. against azole-susceptible and -resistant Candida species
    • Vazquez, J. A., M. Lynch, D. Boikov, and J. Sobel. 1997. In vitro activity of a new pneumocandin antifungal, L-743,872. against azole-susceptible and -resistant Candida species. Antimicrob. Agents Chemother. 41:1612-1614.
    • (1997) Antimicrob. Agents Chemother. , vol.41 , pp. 1612-1614
    • Vazquez, J.A.1    Lynch, M.2    Boikov, D.3    Sobel, J.4
  • 32
    • 0028922813 scopus 로고
    • Fungemia in children infected with the human immunodeficiency virus: New epidemiologic patterns, emerging pathogens, and improved outcome with antifungal therapy
    • Walsh, T. J., C. Gonzalez, E. Roilides, B. U. Mueller, N. Ali, L. L. Lewis, T. O. Whitcomb, D. J. Marshall, and P. A. Pizzo. 1995. Fungemia in children infected with the human immunodeficiency virus: new epidemiologic patterns, emerging pathogens, and improved outcome with antifungal therapy. Clin. Infect. Dis. 20:900-906.
    • (1995) Clin. Infect. Dis. , vol.20 , pp. 900-906
    • Walsh, T.J.1    Gonzalez, C.2    Roilides, E.3    Mueller, B.U.4    Ali, N.5    Lewis, L.L.6    Whitcomb, T.O.7    Marshall, D.J.8    Pizzo, P.A.9
  • 33
    • 0030896919 scopus 로고    scopus 로고
    • In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species
    • Zhanel, G. G., J. A. Karlowsky, G. A. J. Harding, T. V. Balko, S. A. Zelenitsky, M. Friesen, A. Kabani, M. Turik, and D. J. Hoban. 1997. In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species. Antimicrob. Agents Chemother. 41:863-865.
    • (1997) Antimicrob. Agents Chemother. , vol.41 , pp. 863-865
    • Zhanel, G.G.1    Karlowsky, J.A.2    Harding, G.A.J.3    Balko, T.V.4    Zelenitsky, S.A.5    Friesen, M.6    Kabani, A.7    Turik, M.8    Hoban, D.J.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.